Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Sanofi”

Trial of Pimasertib With SAR245409 or Placebo in Ovarian CancerCompleted
NCT01936363Phase 2Updated Dec 12, 2018
Sponsor: EMD Serono
Ovarian Cancer
United States, Australia, Belgium, Canada, France +2 more
Alemtuzumab on Surrogate Markers of Disease Activity and Repair Using Advanced MRI Measures in Subjects With Relapsing Remitting Multiple SclerosisCompleted
NCT01395316Phase 4Updated Dec 7, 2018
Sponsor: University of Chicago
Multiple Sclerosis
Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With CabazitaxelCompleted
NCT01668459Phase 2, Phase 3Updated Dec 4, 2018
Sponsor: Dr Anjali Zarkar
Transitional Cell Carcinoma
United Kingdom
Reduction to Preventive Doses of Enoxaparin After 3 to 6 Months of Treatment With Blood Thinners for Cancer-associated Blood ClotsTerminated
NCT02752607N/AUpdated Nov 26, 2018
Sponsor: Dr. Vicky Tagalakis
Deep Vein Thrombosis
Canada
Decitabine and Clofarabine in Higher Risk Myelodysplastic Syndromes (MDS)Completed
NCT00903760Phase 2Updated Nov 15, 2018
Sponsor: M.D. Anderson Cancer Center
Myelodysplastic Syndrome
United States
Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCTCompleted
NCT00709592Phase 2Updated Nov 9, 2018
Sponsor: Virginia Commonwealth University
Non-Hodgkin's Lymphoma · Leukemia · Multiple Myeloma · Acute Myeloid Leukemia
United States
Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic SyndromeCompleted
NCT00065143Phase 2Updated Nov 7, 2018
Sponsor: M.D. Anderson Cancer Center
Leukemia, Myeloid · Myelodysplastic Syndromes
United States
Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid CancerCompleted
NCT00181168Phase 2Updated Nov 2, 2018
Sponsor: Johns Hopkins University
Thyroid Cancer
United States, France
Avastin and Taxotere for Esophagogastric CancerCompleted
NCT00137813Phase 2Updated Nov 1, 2018
Sponsor: Dana-Farber Cancer Institute
Esophageal Cancer · Gastric Cancer
United States
Satisfaction of Treatment Among Elderly Patients With Insulin TherapyCompleted
NCT01240200Phase 4Updated Oct 31, 2018
Sponsor: Emory University
Diabetes Mellitus
United States
Trial Between a Computer-Guided Insulin Infusion Protocol Versus a Standard Insulin Infusion Algorithm in Medical ICUCompleted
NCT00394524NAUpdated Oct 30, 2018
Sponsor: Emory University
Diabetes or With New Hyperglycemia
United States
Phase I/II Study of Capecitabine Plus Aflibercept to Treat Metastatic Colorectal CancerCompleted
NCT01661972Phase 1, Phase 2Updated Oct 29, 2018
Sponsor: John Strickler, M.D.
Metastatic Colorectal Cancer
United States
Evaluate Recovery of Testosterone for Patients Using EligardCompleted
NCT01136226Phase 4Updated Oct 24, 2018
Sponsor: Chesapeake Urology Research Associates
Prostate Cancer
Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)Completed
NCT02414854Phase 3Updated Oct 23, 2018
Sponsor: Sanofi
Asthma
United States, Argentina, Australia, Brazil, Canada +17 more
Advanced MRI Measures of Repair in Alemtuzumab Treated PatientsCompleted
NCT01307332Phase 3Updated Oct 16, 2018
Sponsor: University of British Columbia
Relapsing Remitting Multiple Sclerosis
Canada
Treatment of Type 2 Diabetes With Long Acting Basal Insulin in JordanCompleted
NCT02606357Phase 4Updated Oct 12, 2018
Sponsor: Sanofi
Diabetes Mellitus, Type 2
Jordan
Basal Bolus Versus Basal Insulin in Type 2 Diabetes Mellitus (T2DM)Completed
NCT00979628Phase 4Updated Oct 10, 2018
Sponsor: Guillermo Umpierrez, MD
Type 2 Diabetes · Hyperglycemia
United States
Clofarabine, Idarubicin, and Cytarabine Combination in Acute Myeloid Leukemia (AML) InductionCompleted
NCT01025154Phase 2Updated Oct 9, 2018
Sponsor: M.D. Anderson Cancer Center
Acute Myeloid Leukemia
United States
Low Dose Thymoglobulin to Protect Kidney Function After Liver TransplantCompleted
NCT00970073NAUpdated Oct 9, 2018
Sponsor: The Cleveland Clinic
Liver Transplantation
United States
Asthma With Nasal PolyposisCompleted
NCT03694847N/AUpdated Oct 3, 2018
Sponsor: Louis-Philippe Boulet
Asthma · Nasal Polyps
Canada
Basal Insulin in the Management of Patients With Diabetic Ketoacidosis (DKA)Completed
NCT00590044Phase 4Updated Sep 26, 2018
Sponsor: Emory University
Diabetic Ketoacidosis
United States
ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous TreatmentWithdrawn
NCT00005645Phase 2Updated Sep 18, 2018
Sponsor: Genzyme, a Sanofi Company
Fallopian Tube Cancer · Metastatic Cancer · Ovarian Cancer · Primary Peritoneal Cavity Cancer
United States
Aminopterin in Treating Patients With Recurrent or Refractory Endometrial CancerWithdrawn
NCT00003821Phase 2Updated Sep 18, 2018
Sponsor: Genzyme, a Sanofi Company
Endometrial Cancer
United States
Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor AgonistCompleted
NCT02738151Phase 4Updated Sep 14, 2018
Sponsor: Sanofi
Diabetes Mellitus, Type 2
United States, Bulgaria, Croatia, Czechia, Denmark +11 more
Study of Sanofi Pasteur's Intradermal Influenza Vaccine (IDflu™) in Adults and Elderly in KoreaCompleted
NCT01215669Phase 4Updated Sep 13, 2018
Sponsor: Sanofi Pasteur, a Sanofi Company
Influenza
South Korea

Previous page Next page